XML 21 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1
Restructuring
6 Months Ended
Sep. 30, 2018
Restructuring and Related Activities [Abstract]  
Restructuring
NOTE 4 – RESTRUCTURING
On May 2, 2018, the Company’s Board of Directors (the “Board”) approved a restructuring plan (“Fiscal 2019 Plan”) to better align its business priorities. The Fiscal 2019 Plan comprises the termination of approximately 800 employees and global facility exits and consolidations. These actions were intended to better align the Company’s cost structure with the skills and resources required to more effectively pursue opportunities in the marketplace and execute the Company’s long-term growth strategy. Costs associated with the Fiscal 2019 Plan are presented in “Other expenses, net” in the Company’s Condensed Consolidated Statement of Operations. Severance and facility exit and consolidation actions under the Fiscal 2019 Plan are expected to be substantially completed by the end of fiscal year 2019. Under the Fiscal 2019 Plan, the Company expects to incur pre-tax charges between approximately $140 million and $160 million (including severance costs between approximately $90 million and $100 million and facility exit and consolidation costs between approximately $50 million and $60 million).
Accrued restructuring severance and exit costs and changes in the accruals during the six months ended September 30, 2018 were as follows:
(in millions)
Accrued Balance at
March 31, 2018
 
Expense
 
Change in
Estimate
 
Payments
 
Accretion
and Other
 
Accrued
Balance at
September 30, 2018
Severance charges
$

 
$
82

 
$
(6
)
 
$
(44
)
 
$

 
$
32

Facility exit charges
7

 
37

 

 
(6
)
 

 
38

Total accrued liabilities
$
7

 
 
 
 
 
 
 
 
 
$
70


The balance at September 30, 2018 includes facility exit accruals of approximately $7 million for plans and actions prior to the Fiscal 2019 Plan.
The severance liabilities are included in “Accrued salaries, wages and commissions” in the Condensed Consolidated Balance Sheets. The facility exit liabilities are included in “Accrued expenses and other current liabilities” and “Other noncurrent liabilities” in the Condensed Consolidated Balance Sheets.